Pertussis: A reemerging infection?;Pertusse - Navracející se infekce?

Epidemiologie, Mikrobiologie, Imunologie

Volumn 56, Issue 2, 2007, Pages 51-65

  Kříž, Bohumír ^a,b   Fabianova K ^a   Maixnerova M ^b   Benes C ^a   Maly M ^a  

^a NATIONAL INSTITUTE OF PUBLIC HEALTH   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Immunogenicity; Pertussis; Reactogenicity; Surveillance; Vaccine; Vaccine protective effect

Indexed keywords

DIPHTHERIA VACCINE;

ANTIBODY TITER; ARTICLE; BACTERIUM CULTURE; BORDETELLA PERTUSSIS; CHILDHOOD DISEASE; CZECH REPUBLIC; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIPHTHERIA; DISEASE SURVEILLANCE; DRUG EFFICACY; HUMAN; IMMUNIZATION; IMMUNOGENICITY; INCIDENCE; INFANT MORTALITY; MEASLES; MORBIDITY; PERTUSSIS; SEROLOGY;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; CZECH REPUBLIC; HUMANS; INCIDENCE; INFANT; MIDDLE AGED; PERTUSSIS VACCINE; PREVALENCE; VACCINATION; WHOOPING COUGH;

EID: 34249719954     PISSN: 12107913     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Advisory Committee. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine. MMWR, 2006, 55, No. RR-17.
2. Andersen, K. E. Serological Studies on H. pertussis, H. parapertussis and H. bronchisepticus. Acta Pathol Microbiol Scand, 1953, 33, 2, 202-224.
3. Bakoss, P. Epidemiológia. Bratislava: Univerzita Komenského, 2005, 488 s.
4. Bednář, M., Fraňková, V., Schindler, J., Souček, A., Vávra, J. Lékařská mikrobiologie. Praha: Marvil, 1996, 558s.
5. Bisgard, K. M., Rhodes, S. P., Connelly, B. L., Bi, D. et al. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001. Pediatrics, 2005, 116, 285-294.
6. Celentano, L. P., Massari, M., Paramatti, D., Salmaso, S. et al. Resurgence of pertussis in Europe. Pediatr Infect Dis J., 2005, 24, 9, 761-765.
7. Crowwcroft, N. S., Britto, J. Whooping cough- a continuing problem. BMJ, 2002, 324, 1537-1538.
8. De Carvalho, A. P., Pereira, E. M. Acellular pertussis vaccine for adolescents. J Pediatr (Rio J), 2006, 82, 3, 15-24.
9. De Greeff, S., Schellekens, J., Frits, M., de Melker, H. Pertussis incidence in the Netherlands after introduction of an acellular booster vaccination at 4 years of age. Eurosurveillance Weekly, 2004, 8, 27.
10. De Melker, H.E., Conyn-van Spaendonck, M.A.E., Rumke, H.C., van Wiljngaarden, J.K. et al. Pertussis in the Netherlands: an outbreak despite high levels of immunization with whole-cell vaccine. Emerging Infectious Diseases, 1997, 3, 175-178.
11. Duřpektová, M., Hrstková, H., Valníčková, Z. Problematika pertuse v dětském věku. Čs Pediatr, 2006, 61, 1, 6-11.
12. Eldering, G., Holwerda, J., Davis, A., Baker, J. Bordetella pertussis Serotypes in the United States. Appl Microbiol, 1969, 18, 4, 618-621.
13. Eldering, G., Hornbeck, C., Baker, J. Serological Study of B. pertussis and related species. J Bacteriol, 1957, 74, 2, 133-136.
14. EPIDAT, Národní referenční centrum pro analýzu epidemiologických dat, SZÚ.
15. Fischer, L., Veselý, V. Zákonná ustanovení o potírání nakažlivých chorob. Praha: Příruční knihovna časopisu "Praktický lékař" Svazek XVIII, 1928, II rozšířené vydání, 79 s.
16. Fry, N. K, Tzivra, O., Li Y. T., McNiff, A. et al. Laboratory diagnosis of pertussis infections: the role of PCR and serology. J Med Microbiol, 2004, 53, 6, 519-525.
17. Gilberg, S., Njamkepo E., du Chatelet, I. P., Partouche, H. et al. Evidence of Bordetella pertussis infection in adults presenting with persistent cough in a French area with very high whole-cell vaccine coverage. J Infect Dis, 2002, 186, 415-418.
18. Gri1c, E., Pirnat, N. Pertussis outbreak in recently vaccinated children in a kindergarten in Ljubljana during a resurgence in pertussis incidence. Euro Surveill, 2005, 10, 8, E050818.4.
19. Guris, D., Strebel, P. M., Bardenheier B., Brennan, M. et al. Changing epidemiology of pertussis in the United States: Increasing reported incidence among adolescents and adults, 1990-1996. Clin Infect Dis, 1999, 28, 1230-1237.
20. Harnden, A., Grant, C., Harrison, T., Perera, R. et al. Whooping cough in school age children with persistent cough: prospective cohort study in primary care. BMJ, 2006, 333, 7560, 159-160.
21. Holčíková, A., Štroblová, H., Jirsenská, Z. Může být stanovení IgG protilátek k pertussovému toxinu pro diagnostiku nemoci přínosem? Klinická mikrobiologie a infekční lékařství, 2006, 12, 5, 184-188.
22. Cherry, J. D. The epidemiology of pertussis: a comparison of the epidemiology of the disease pertussis with the epidemiology of Bordetella pertussis infection. Pediatrics, 2005, 15, 1422-1427.
23. Christodoulides, M. Pertussis vaccines: present status. Adv Biotechnol Processes, 1990, 13, 169-199.
24. Kříž, B., Částková, J., Beneš, Č., Maixnerová, M., Fabiánová, K. Pertusse - vracející se infekce? In II. Hradecké vakcinologické dny, 19.10.-21.10.2006: sborník abstrakt, 2006, s. 18.
25. Lobovská, A. Infekční nemoci. Univerzita Karlova v Praze: Nakladatelství Karolinum, 2002. 263 s.
26. Maixnerová, M., Vysoká-Buriánová, B., Stránský, V. Surveillance of whooping cough in Czechoslovakia. II. Incidence of antigenic types of B.pertussis in Czechoslovakia in the years 1966-1970. J Hyg Epidemiol Microbiol Immunol, 1972, 16, 267-272.
27. Maixnerová, M. The 2001 Serological survey in the Czech Republic - pertussis. Cent Eur J Public Health, 2003, 11, Suppl., 23-24.
28. Maixnerová, M. The 2001 Serological survey in the Czech Republic - parapertussis. Cent Eur J Public Health, 2003, 11, Suppl. 23-24.
29. Maixnerová, M. Současná problematika dávivého kašle. Vox pediatrie, 2005, 5, 4, 22-24.
30. Marešová, V. Očkovací látky pro děti dostupné v ČR. Pediatrie pro praxi, 2001, 2, 1, 17-18.
31. Matter, H. C. Whooping cough in Switzerland. Eurosurveillance Weekly, 1997, 1, 35.
32. Matoo, S., Cherry, J. D. Molecular Pathogenesis, Epidemiology, and Clinical Manifestations of Respiratory Infections Due to Bordetella pertussis and Other Bordetella Subspecies. Clin Microbiol Rev, 2005, 18, 2, 326-382.
33. Miller, E., Fleming, D. M., Ashworth, L. A., Mabbett, D. A. et al. Serological evidence of pertussis in patients presenting with cough in general practice in Birmingham. Commun Dis Public Health, 2000, 3, 2, 132-134.
34. Mink, C. A., Sirota, N. M., Nugent, S. Outbreak of pertussis in a fully immunized adolescent and adult population. Arch Pediatr Adolesc Med, 1994, 148, 2, 153-157.
35. Mitchell, A. A., Liddell, K. G., Criggie, W. Adult pertussis in a general practice. Health Bull (Edinb), 2000, 58, 1, 34-37.
36. Neppelenbroek, S. E., de Melker, H. E., Schellekens, J. F. P., Conynvan, M. A. E. The incidence of pertussis in the Netherlands has remained high since an outbreak occurred in 1996. Eurosurveillance Weekly, 1997, 5, 5, 970529.
37. Neppelenbroek, S. E., de Melker, H. E. The incidence of pertussis in the Netherlands has remained high since an outbreak occurred in 1996. Surveillance report, 1999, 4, 12, 133-134.
38. Ntezayabo, B., De Serres, G., Duval, B. Pertussis resurgence in Canada largely caused by a cohort effect. Pediatr Infect Dis J, 2003, 22, 22-27.
39. Olin, P., Rasmussen F., Gustafsson, L., Hallander, H. O. et al. Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine. Ad Hoc Group for the Study of Pertussis Vaccines. Lancet, 1997, 350, 9091, 1569-1577.
40. Pebody, R. G., Gay, N. J., Giammanco, A., Baron, S. et al. The seroepidemiology of Bordetella pertussis infection in Western Europe. Epidemiol Infect, 2005, 133, 1, 159-171.
41. Pelc, H. Zdravotní stav obyvatelstva Československé republiky v jejím prvním desetiletí. Praha, 1929. 183 s.
42. Pichichero, M. E., Deloria, M. A., Rennels, M. B., Anderson, E. L. et al. A Safety and Immunogenicity Comparison of 12 Acellular Pertussis Vaccines and One Whole-Cell Pertussis Vaccine Given as a Fourth Dose in 15- to 20-Month-Old Children. Pediatrics 1997, 100, 772-788.
43. Pittmann, M. Neurotoxicity of Bordetella pertussis. Neurotoxicology. 1986, 7, 2, 53-68.
44. Procházka, J., Kryl, R. Problematika pertuse. Prakt Lék, 1959, 6, 241-246.
45. Rendi-Wagner, P., Kundi, M., Mikolasek, A., Vecsei, A. et al. Hospital-based active surveillance of childhood pertussis in Austria from 1996 to 2003: estimates of incidence and vaccine effectiveness of whole-cell and acellular vaccine. Vaccine, 2006, 24, 33-34.
46. Senzilet, L. D., Halperin, S. A., Spika, J. S., Alagaratnam, M. et al. Pertussis is a frequent cause of prolonged cough illness in adult and adolescent. Clin Infect Dis, 2001, 32, 15, 1691-1697.
47. Salmaso, S. and the Eurosurveillance editorial team. Pertussis vaccine schedules across Europe. Euro Surveillance, 1999, 4, 12, 127.
48. Schellekens, J., Von Konig, C.H., Gardner, P. Pertussis sources of infection and routes of transmission in the vaccination era. Pediatr Infect Dis J, 2005, 24, 5, 19-24.
49. Socan, M., Prosenc, K., Vegnuti, M. Seroprevalence of IgG antibodies to pertussis toxin in the Slovene population. Wien Klin Wochenschr, 2006, 118, 11-12, 336-340.
50. Stejskalová, M., Kolková, A., Koutová, J. Výskyt pertuse a parapertuse v dětských kolektivech na území hl. města Prahy. Prakt Lék., 1959, 6, 246-248.
51. Storsaeter, J., Wolter, J. Is there a need for a new generation of vaccines against pertussis? Expert Opin Emerg Drugs, 2006, 11, 2, 195-205.
52. Škovránková, J., Komárek, V., Maděrová, K. Indikace očkování proti tetanum záškrtu a černému kašli vakcínou obsahující acelulární pertusovou složku. Pediatrie pro praxi, 2004, 2, 67-68.
53. Tan, T., Trindade, E., Skowronski, D. Epidemiology of pertussis. Pediatr Infect Dis J, 2005, 24, 5, 10-18.
54. Todar, K. Bordetella pertussis and Whooping Cough. [Todar's Online Textbook of Bacteriology] rev. 2006. Dostupný z WWW: < /pertussis.html>
55. Trollfors, B., Taranger, J., Lagergard, T., Sundh, V. Reduced immunogenicity of diphtheria and tetanus toxoids when combined with pertussis toxoid. Pediatr Infect Dis J, 2005, 24, 1, 85-86.
56. Víceúčelový sérologický přehled protilátek proti vybraným infekcím, u nichž se provádí očkování. Zprávy CEM, 2003, 12, (příloha 1), 65 s.
57. Vickers, D., Ross, A. G., Mainar-Jaime, R. C., Neudorf, C., Shah, S. Whole-cell and acellular pertussis vaccination programs and rates of pertussis among infants and young children. CMAJ, 2006, 175, 10, 1213-1217.
58. Von Konig, C. H., Halperin, S., Riffelmann, M., Guiso, N. Pertusis of adults and infants. Lancet Infect Dis, 2002, 2, 12, 744-750.
59. Vospělová, J., Zapletalová, J. Stále aktuální pertuse. Pediatrie pro praxi, 2004, 4, 204-206.
60. Vysoká-Buriánová, B. K současné problematice epidemiologie dávivého kašle. Česk Epidemiol Mikrobiol Imunol, 1963, XII, 3, 158-168.
61. Vysoká-Buriánová, B. Epidemiologie. 1. vyd. Praha: Avicenum, 1981, 298 s.
62. Vysoká-Buriánová, B., Maixnerová, M. Dávivý kašel v ČSR v roce 1973 a problémy v diagnostice. Česk Pediatr, 1974, 29, 6, 325-328.
63. Vysoká-Buriánová, B., Burian, V., Maixnerová, M. The Role of Antigenic Types of Bordetella pertussis Strains in Vaccines and the Immunological Answer in Children. International symposium on pertussis, Bilthoven, 1969, in Symp. series immunobiol. standard, Karger, Basel, München, New York, 1970, 13, 132-137.
64. Vysoká-Buriánová, B. Pertusse - Parapertusse. Praha, disertační práce, 1961. 122 s.
65. www.who.int/topics/pertussis/en [online] [cited 2006-11-10]
66. World Health Organization. CD Update. Communicable Diseases Report, 1997, 1-4.